CDH2 and ovarian cancer: Recent studies show that ovarian cancer cell metastatic properties, aggregation dynamics, MCA surface morphology, inner ultrastructure and behavior differ among epithelial, intermediate and mesenchymal phenotypes and are regulated by E- and Ncad expression both in their free-floating state [43] and at the secondary metastatic site [45].